SBI US Gateway Fund

Funding rounds backed by SBI US Gateway Fund.

Export CSV
Funding disclosed in full
$3.7M
Median round
$3.7M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Sift Biosciences

Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases

$3.7MPre-SeedBiotechUnited States
5 participantsEisai InnovationFreeflow VenturesLifespan Vision VenturesSBI US Gateway FundValuence Ventures